SNOMED CT Concept  138875005

Observable entity  363787002

Proliferative mass observable  1145211006

Neoplasm observable   395531003

SNOMED CT code


SNOMED code395531003
nameNeoplasm observable
statusactive
date introduced2003-01-31
fully specified name(s)Neoplasm observable (observable entity)
synonyms
  • Tumour observable
  • Tumor observable
  • Neoplasm observable
parentsProliferative mass observable   1145211006
children
  • Additional pathologic finding in tumor specimen   371498006
  • Allred score for neoplasm   445104009
  • Anatomic location of excised lymph node containing metastatic neoplasm   397440000
  • Anatomic location of neoplasm   371480007
  • Average intensity of positive staining neoplastic cells   444775005
  • Clockface position of neoplasm   443772002
  • Degree of pigmentation of tumor   399574005
  • Detection of neoplasm in body fluid   1285453009
  • Distance from anterior edge of tumor to limbus of cornea at cut edge, after sectioning   396987006
  • Distance of anterior margin of tumor base from limbus of cornea at cut edge, after sectioning   399514000
  • Distance of posterior margin of tumor base from edge of optic disc, after sectioning   396988001
  • Distance of tumor from anal verge   371490004
  • Dukes stage   385357003
  • Edition of American Joint Commission on Cancer, Cancer Staging Manual used for TNM staging   443941007
  • FIGO stage for gynecological malignancy   385361009
  • Functional status of pancreatic endocrine tumor   396893004
  • Generic tumor extent   258263003
  • Histologic feature of neoplasm   396984004
  • Intergroup rhabdomyosarcoma study post-surgical clinical group   405916000
  • International neuroblastoma pathology classification   409728006
  • Intraoperative presence of metastasis in sentinel lymph node by one-step nucleic acid amplification   1285487004
  • Laterality of primary malignant neoplasm of oral soft tissue   1286852000
  • Laterality of primary malignant neoplasm of pharynx   1286919007
  • Length dimension of neoplasm   263605001
  • Length of largest lymph node with metastatic neoplasm in excised specimen   1279923008
  • Linear extent of involvement of carcinoma   385300008
  • Location of malignant melanoma in specimen with involved deep margin   425133002
  • Location of malignant melanoma in specimen with uninvolved lateral margin   424696000
  • Location of melanoma in situ in specimen with uninvolved lateral margin   422796005
  • Location of tumor in relation to closest lateral margin   406013004
  • Location of tumor within eye   399725006
  • Location of tumor within lateral margin   406014005
  • Lymphoma extent of involvement   397447002
  • Mitotic-karyorrhectic index   1290247007
  • Modified Dukes stage   103420007
  • National Wilms Tumor Study Group Stage   405931009
  • Neoplasm weight   371503009
  • Nottingham mitotic count in primary malignant neoplasm of breast   3010001000004101
  • Number fraction of estrogen receptors in neoplasm using immune stain   444644009
  • Number fraction of progesterone receptors in neoplasm using immune stain   445366002
  • Number of metastatic discontinuous tumor deposits of primary malignant neoplasm of appendix   1256030002
  • Number of metastatic discontinuous tumor deposits of primary malignant neoplasm of cecum and/or colon and/or rectum   1286756005
  • Number of neoplasms in excised tissue specimen   246214002
  • Number of positive prostatic tissue chips obtained by resection   372282003
  • Number of tissue chips positive for carcinoma   399589001
  • Number of tumor buds in primary malignant neoplasm of cecum and/or colon and/or rectum in microscopic field 0.785 square millimeter   1286758006
  • Number of tumor nodules   405930005
  • Organ AND/OR tissue involved by tumor   399483003
  • Pathologic stage   405978005
  • Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm by immunohistochemistry   1255078008
  • Percent of cells with estrogen receptor in primary malignant neoplasm of breast by immunohistochemistry   1234804006
  • Percent of cells with progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry   1234803000
  • Percent of neoplasm in primary malignant mixed germ cell tumor of testis   1287132008
  • Percent thickness of myometrial wall directly invaded by adenosarcoma in uterus specimen   1285137001
  • Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy   1285327002
  • Percentage of carcinoma in situ in neoplasm   444916005
  • Percentage of immature teratoma involved by immature elements   1290243006
  • Percentage of neoplasm involved by necrosis   405921002
  • Percentage of primary malignant neoplasm of prostate in resected prostate specimen   1525831000004108
  • Percentage of primary malignant neoplasm of prostate with Gleason histologic pattern 4   1287180006
  • Percentage of sarcomatoid element in tumor   399653000
  • Percentage span of neoplasm consisting of epithelium   445234005
  • Percentage span of neoplasm consisting of stroma   445233004
  • Presence of ALK tyrosine kinase receptor in primary malignant neoplasm of lung by immunohistochemistry   1255768001
  • Presence of anaplasia in malignant neoplasm   1279996006
  • Presence of anoctamin-1 in primary gastrointestinal stromal sarcoma by immunohistochemistry   1255615003
  • Presence of direct invasion by neoplasm   371487005
  • Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry   1286752007
  • Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of endometrium by immunohistochemistry   1255083000
  • Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of lung by immunohistochemistry   1255098003
  • Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry   1286764004
  • Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of endometrium by immunohistochemistry   1255089001
  • Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of lung by immunohistochemistry   1255099006
  • Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry   1286763005
  • Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of endometrium by immunohistochemistry   1255090005
  • Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of lung by immunohistochemistry   1255100003
  • Presence of ductal carcinoma in situ in epidermis of nipple   2900001000004101
  • Presence of ductal carcinoma in situ in excised breast specimen   1240396004
  • Presence of estrogen receptor in neoplasm   445028008
  • Presence of hepatoblastoma in serous capsule of liver in excised specimen   1275630008
  • Presence of implants of primary malignant neoplasm of uterine adnexa   1268932000
  • Presence of invasive ductal carcinoma with extensive intraductal carcinoma in excised breast specimen   1281845003
  • Presence of lobular carcinoma in situ in excised breast specimen   1240402007
  • Presence of mast/stem cell growth factor receptor Kit in primary gastrointestinal stromal sarcoma by immunohistochemistry   1255614004
  • Presence of metastasis in sentinel lymph node using touch imprint cytology during surgical procedure   1285486008
  • Presence of metastatic discontinuous spread of primary malignant neoplasm   1730561000004108
  • Presence of metastatic neoplasm in lymph node in excised tissue specimen   1268302004
  • Presence of microsatellite of malignant melanoma   1264484006
  • Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry   1286762000
  • Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of endometrium by immunohistochemistry   1255091009
  • Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of lung by immunohistochemistry   1255097008
  • Presence of necrosis in ductal carcinoma in situ in excised breast specimen   1287179008
  • Presence of neoplasm at excised surgical margin   371488000
  • Presence of neoplasm in mesentery   1287135005
  • Presence of nephrogenic rests in primary nephroblastoma   1264289004
  • Presence of neurotropism in malignant melanoma of skin   1264483000
  • Presence of progesterone receptor in neoplasm   445029000
  • Presence of programmed cell death 1 ligand 1 in primary malignant neoplasm of lung by immunohistochemistry   1255770005
  • Presence of proto-oncogene tyrosine-protein kinase ROS in primary malignant neoplasm of lung by immunohistochemistry   1255769009
  • Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of breast by immunohistochemistry   3550001000004108
  • Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of endometrium by immunohistochemistry   1255095000
  • Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of lung by immunohistochemistry   1255771009
  • Presence of regression of metastatic neoplasm of breast in lymph node after neoadjuvant antineoplastic therapy   1256123005
  • Presence of regression of primary malignant melanoma of skin   1255605009
  • Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy   1255588004
  • Presence of regression of primary malignant neoplasm of prostate after hormone therapy   1285517009
  • Presence of regression of primary malignant neoplasm of prostate after radiotherapy therapy   1285516000
  • Presence of succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry   1255616002
  • Presence of succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry   1255617006
  • Presence of tumor bud in primary malignant neoplasm of cecum and/or colon and/or rectum   1286751000
  • Presence of tumor necrosis in malignant neoplasm of bone in excised tissue specimen   1285296002
  • Presence of tumor necrosis in malignant neoplasm of kidney in excised kidney specimen   1269402006
  • Presence of tumor necrosis in malignant neoplasm of soft tissue in excised specimen   1287172004
  • Presence of tumor necrosis in malignant neoplasm of thyroid in thyroidectomy specimen   1279927009
  • Presence of ulcer in primary malignant melanoma of skin   6270001000004106
  • Proportion of specimen involved by tumor   371510003
  • Proportion score of neoplastic cells positive for hormone receptors using immunohistochemistry   444901007
  • Radial location of malignant melanoma in peripheral surgical margin of excised specimen of skin   422973004
  • Radial location of melanoma in situ in peripheral surgical margin of excised skin specimen   424082007
  • Radial location of neoplasm in excised breast specimen   1290348000
  • Region of fallopian tube involved by tumor   399429001
  • Relative location of involved inguinal lymph nodes to primary malignant neoplasm of penis   1286943005
  • Relative location of involved lymph nodes to primary malignant neoplasm of nasal cavity and/or nasal sinus   1287131001
  • Relative location of involved lymph nodes to primary malignant neoplasm of oral soft tissue   1286862007
  • Relative location of involved lymph nodes to primary malignant neoplasm of pharynx   1286920001
  • Relative location of involved lymph nodes with primary malignant neoplasm of major salivary gland   1286891005
  • Residual cancer burden index   444782009
  • Residual tumor   17964000
  • Serum tumor marker category   399424006
  • Serum tumor marker status values   313137003
  • Site involved by extension of neoplasm   443787007
  • Site of direct extension of tumor   399520004  removed: 2010-01-31
  • Site of invasive ovarian tumor omental implant   399613003
  • Site of largest single mass   397443003
  • Site of non-invasive (desmoplastic) ovarian tumor omental implant   397512008
  • Site of non-invasive (epithelial) ovarian tumor omental implant   397510000
  • Stage of tumor involvement of non-regional lymph nodes   371495009
  • Status of adrenal gland involvement by tumor   396210009
  • Status of correlation between radiographic image and pathologic finding   425911000
  • Status of distant metastasis   399608002
  • Status of intratumoral/peritumoral lymphocyte response   384604004
  • Status of invasive ovarian tumor omental implants   399428009
  • Status of non-invasive (desmoplastic) ovarian tumor omental implants   397511001
  • Status of non-invasive (epithelial) ovarian tumor omental implants   397505004
  • Status of ovarian tumor omental implants   399668004
  • Status of regression of tumor   396432002
  • Status of renal sinus involvement by tumor   405926007
  • Status of residual neoplasm   445200009
  • Status of specimen involvement by macroscopic tumor   399489004
  • Status of specimen involvement by multifocal invasion   444696007
  • Status of specimen involvement by satellite nodule(s)   396406008
  • Status of tumor infiltration by lymphocytes   396395003
  • Status of tumor involvement by anaplasia   405908009  removed: 2023-05-31
  • Status of tumor involvement by necrosis   405909001
  • Status of tumor metastasis to non-regional lymph nodes   396786009
  • Status of tumor metastasis to regional lymph nodes   399656008
  • Surgical margin involved by neoplasm in excised tissue specimen   396324006
  • TNM tumor observable   399631002
  • Total Gleason score   384997002  removed: 2021-07-31
  • Tumor border behavior   370110004
  • Tumor bud score in primary malignant neoplasm of cecum and/or colon and/or rectum   1286754008
  • Tumor configuration   371500007
  • Tumor extent of invasion, macroscopic   396402005
  • Tumor focality   396199003
  • Tumor immunophenotyping status   371511004
  • Tumor location after sectioning   396985003
  • Tumor measureable   396238001  removed: 2021-07-31
  • Tumor nodule site   406084004
  • Tumor pigmentation   396410006
  • Tumor quantitation   385404000
  • Tumor stage   371508000
  • Tumor viability   396793008
  • Tumor volume   258261001
  • Type of polyp from which malignant neoplasm originated   406126002
  • Type of study performed on tumor specimen   396926000
  • WHO tumor classification   397005006
  • WHO tumor classification cannot be determined   397006007
hierarchies
a selection of possible paths
SNOMED CT Concept   138875005
  Observable entity   363787002
    Proliferative mass observable   1145211006
      Neoplasm observable   395531003

ancestors
sorted most to least specific
cpt crosswalks

Rules-based maps relating CPT® codes to and from SNOMED CT® clinical concepts.  Forward and backward mapping allows for easy transition between code sets. Map-A-Code crosswalk tool easily crosswalks multiple codes between the code sets.

Access to this feature is available in the following products:
  • CPT® to SNOMED Crosswalks

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.